DexCom (DXCM)'s Market Value Suffers $6.24 Slide on October 11, 2023
DXCM faced a turbulent day on October 11, 2023, with a $6.24 loss in stock value, signifying a substantial 7.32% decrease from the prior day's closing price.
by Surya
Updated Oct 12, 2023
Article continues below advertisement
DexCom (DXCM)'s Market Value Suffers $6.24 Slide
DexCom
NASDAQ: DXCM
October 11th : $78.97
−6.24 (7.32%)
On October 11th, 2023, DexCom (NASDAQ: DXCM) exhibited a significant drop in value compared to the previous day's closing price. The stock opened at $84.31, which was notably lower than the prior day's closing price of $85.21. Throughout the trading day, DXCM experienced a price range between the daily high of $85.02 and the low of $77.91, reflecting a considerable intraday fluctuation. It eventually closed at $78.97, signifying a 7.32% or − $6.24 decrease from the previous day's value. After hours, DXCM saw a modest recovery, with the price at $79.30, indicating a 0.42% increase.
-market-value-october-11,-2023-65279fb90b76b97945507-900.webp)
DexCom's 52-week performance demonstrated a substantial variance, with the stock's highest point in the past year reaching $139.55 and the lowest at $77.91. The market capitalization stood at an impressive $30.63B, illustrating the company's substantial valuation. The P/E (Price-to-Earnings) ratio for DXCM was notably high at 94.25, suggesting a premium on the stock's earnings relative to its share price.
|
Metric |
Value |
|
Current Price |
$78.97 |
|
Price Change Today |
-$6.24 (-7.32%) |
|
Opening Price |
$84.31 |
|
Daily High |
$85.02 |
|
Daily Low |
$77.91 |
|
After-Hours Price |
$79.30 USD (+0.42%) |
|
52-Week High |
$139.55 |
|
52-Week Low |
$77.91 |
|
Market Capitalization |
$30.63B |
|
P/E Ratio |
94.25 |
Related Articles
What is Overbought and Oversold?
138 days ago
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.